Read Books Online and Download eBooks, EPub, PDF, Mobi, Kindle, Text Full Free.
A Year In Review Discussions In Cancer Immunity And Immunotherapy
Download A Year In Review Discussions In Cancer Immunity And Immunotherapy full books in PDF, epub, and Kindle. Read online A Year In Review Discussions In Cancer Immunity And Immunotherapy ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Book Synopsis A year in review: Discussions in cancer immunity and immunotherapy by : Catherine Sautes-Fridman
Download or read book A year in review: Discussions in cancer immunity and immunotherapy written by Catherine Sautes-Fridman and published by Frontiers Media SA. This book was released on 2023-06-07 with total page 148 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Book Synopsis Cancer Immunology and Immunotherapy by : Mansoor M. Amiji
Download or read book Cancer Immunology and Immunotherapy written by Mansoor M. Amiji and published by Academic Press. This book was released on 2021-08-18 with total page 550 pages. Available in PDF, EPUB and Kindle. Book excerpt: Delivery Technologies for Immuno-Oncology: Volume 1: Delivery Strategies and Engineering Technologies in Cancer Immunotherapy examines the challenges of delivering immuno-oncology therapies. Immuno-oncology (IO) is a growing field of medicine at the interface of immunology and cancer biology leading to development of novel therapeutic approaches, such as chimeric antigen receptor T-cell (CAR-T) and immune checkpoint blockade antibodies, that are clinically approved approaches for cancer therapy. Although currently approved IO approaches have shown tremendous promise for select types of cancers, broad application of IO strategies could even further improve the clinical success, especially for diseases such as pancreatic cancer, brain tumors where the success of IO so far has been limited. Nanotechnology-based targeted delivery strategies could improve the delivery efficiency of IO agents as well as provide additional avenues for novel therapeutic and vaccination strategies. Additionally, a number of locally-administered immunogenic scaffolds and therapeutic strategies, such as the use of STING agonist, could benefit from rationally designed biomaterials and delivery approaches. Delivery Technologies for Immuno-Oncology: Volume 1: Delivery Strategies and Engineering Technologies in Cancer Immunotherapy creates a comprehensive treaty that engages the scientific and medical community who are involved in the challenges of immunology, cancer biology, and therapeutics with possible solutions from the nanotechnology and drug delivery side. - Comprehensive treaty covering all aspects of immuno-oncology (IO) - Novel strategies for delivery of IO therapeutics and vaccines - Forecasting on the future of nanotechnology and drug delivery for IO
Book Synopsis A Year in Review: Discussions in Immunological Memory by : Scott N. Mueller
Download or read book A Year in Review: Discussions in Immunological Memory written by Scott N. Mueller and published by Frontiers Media SA. This book was released on 2022-11-30 with total page 138 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Book Synopsis The Breakthrough by : Charles Graeber
Download or read book The Breakthrough written by Charles Graeber and published by Hachette+ORM. This book was released on 2015-12-01 with total page 314 pages. Available in PDF, EPUB and Kindle. Book excerpt: Follow along as this New York Times bestselling author details the astonishing scientific discovery of the code to unleashing the human immune system to fight in this "captivating and heartbreaking" book (The Wall Street Journal). For decades, scientists have puzzled over one of medicine's most confounding mysteries: Why doesn't our immune system recognize and fight cancer the way it does other diseases, like the common cold? As it turns out, the answer to that question can be traced to a series of tricks that cancer has developed to turn off normal immune responses -- tricks that scientists have only recently discovered and learned to defeat. The result is what many are calling cancer's "penicillin moment," a revolutionary discovery in our understanding of cancer and how to beat it. In The Breakthrough, New York Times bestselling author of The Good Nurse Charles Graeber guides readers through the revolutionary scientific research bringing immunotherapy out of the realm of the miraculous and into the forefront of twenty-first-century medical science. As advances in the fields of cancer research and the human immune system continue to fuel a therapeutic arms race among biotech and pharmaceutical research centers around the world, the next step -- harnessing the wealth of new information to create modern and more effective patient therapies -- is unfolding at an unprecedented pace, rapidly redefining our relationship with this all-too-human disease. Groundbreaking, riveting, and expertly told, The Breakthrough is the story of the game-changing scientific discoveries that unleash our natural ability to recognize and defeat cancer, as told through the experiences of the patients, physicians, and cancer immunotherapy researchers who are on the front lines. This is the incredible true story of the race to find a cure, a dispatch from the life-changing world of modern oncological science, and a brave new chapter in medical history.
Book Synopsis Tumor Immunology and Immunotherapy by : Robert C. Rees
Download or read book Tumor Immunology and Immunotherapy written by Robert C. Rees and published by Oxford University Press, USA. This book was released on 2014 with total page 469 pages. Available in PDF, EPUB and Kindle. Book excerpt: Tumor immunology and immunotherapy provides a comprehensive account of cancer immunity and immunotherapy. Examining recent results, current areas of interest and the specific issues that are affecting the research and development of vaccines, this book provides insight into how these problems may be overcome as viewed by leaders in the field.
Book Synopsis Cancer Immunotherapy Principles and Practice by : Lisa H. Butterfield
Download or read book Cancer Immunotherapy Principles and Practice written by Lisa H. Butterfield and published by . This book was released on 2017 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: Part 1: Intratumoral Signatures Associated With Immune Responsiveness
Book Synopsis Immunotherapy of Hepatocellular Carcinoma by : Tim F. Greten
Download or read book Immunotherapy of Hepatocellular Carcinoma written by Tim F. Greten and published by Springer. This book was released on 2018-08-22 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: In this book we provide insights into liver – cancer and immunology. Experts in the field provide an overview over fundamental immunological questions in liver cancer and tumorimmunology, which form the base for immune based approaches in HCC, which gain increasing interest in the community due to first promising results obtained in early clinical trials. Hepatocellular carcinoma (HCC) is the third most common cause of cancer related death in the United States. Treatment options are limited. Viral hepatitis is one of the major risk factors for HCC, which represents a typical “inflammation-induced” cancer. Immune-based treatment approaches have revolutionized oncology in recent years. Various treatment strategies have received FDA approval including dendritic cell vaccination, for prostate cancer as well as immune checkpoint inhibition targeting the CTLA4 or the PD1/PDL1 axis in melanoma, lung, and kidney cancer. Additionally, cell based therapies (adoptive T cell therapy, CAR T cells and TCR transduced T cells) have demonstrated significant efficacy in patients with B cell malignancies and melanoma. Immune checkpoint inhibitors in particular have generated enormous excitement across the entire field of oncology, providing a significant benefit to a minority of patients.
Book Synopsis Anti-tumor Activity of Cytotoxic Immune Cells: Basic Research and Clinical Perspectives by : Malgorzata Firczuk
Download or read book Anti-tumor Activity of Cytotoxic Immune Cells: Basic Research and Clinical Perspectives written by Malgorzata Firczuk and published by Frontiers Media SA. This book was released on 2024-05-24 with total page 121 pages. Available in PDF, EPUB and Kindle. Book excerpt: Cytotoxic T lymphocytes (CTL) and natural killer (NK) cells are powerful effectors of antitumor immunity. CTL recognize tumor antigens presented by human leukocyte antigen (HLA) molecules with antigen-specific T cell receptors (TCR) and are the key effector cells of the adaptive immune response. In contrast, NK cells lack antigen-specific receptors and are regulated by the balance of signals from activating and inhibitory receptors. These two types of cells cooperate and complement each other in eliciting host immune response to cancer and mediating immune surveillance. Moreover, these cells play a crucial role in antitumor immunotherapy, including monoclonal antibodies (mAbs), bispecific T cell engagers (BiTe), as well as adoptive transfer of chimeric antigen receptor (CAR)-modified cytotoxic cells.
Book Synopsis Tumor Microenvironment, Inflammation, and Resistance to Immunotherapies by : Apostolos Zaravinos
Download or read book Tumor Microenvironment, Inflammation, and Resistance to Immunotherapies written by Apostolos Zaravinos and published by Frontiers Media SA. This book was released on 2023-06-29 with total page 218 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Book Synopsis Tumor-Associated Antigens and Their Autoantibodies: From Discovering to Clinical Utilization by : Xiangqian Guo
Download or read book Tumor-Associated Antigens and Their Autoantibodies: From Discovering to Clinical Utilization written by Xiangqian Guo and published by Frontiers Media SA. This book was released on 2022-08-18 with total page 192 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Book Synopsis NK cell modifications to advance their anti-tumor activities by : Ye Li
Download or read book NK cell modifications to advance their anti-tumor activities written by Ye Li and published by Frontiers Media SA. This book was released on 2023-09-08 with total page 198 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Book Synopsis Immune Cell Lineage Reprogramming in Cancer by : Jianmei Wu Leavenworth
Download or read book Immune Cell Lineage Reprogramming in Cancer written by Jianmei Wu Leavenworth and published by Frontiers Media SA. This book was released on 2022-02-22 with total page 244 pages. Available in PDF, EPUB and Kindle. Book excerpt: Topic Editor Dr. Lewis Shi received financial support from Varian Medical System, Inc. The other Topic Editors declare no competing interests with regard to the Research Topic subject.
Book Synopsis Tumor-promoting immune cells: Cancer immune escape and beyond by : Nicolas Larmonier
Download or read book Tumor-promoting immune cells: Cancer immune escape and beyond written by Nicolas Larmonier and published by Frontiers Media SA. This book was released on 2023-03-31 with total page 198 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Book Synopsis Delivering Nucleic Acids to Immune and Non-Immune Cells by : Francesca Re
Download or read book Delivering Nucleic Acids to Immune and Non-Immune Cells written by Francesca Re and published by Frontiers Media SA. This book was released on 2024-02-16 with total page 231 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Book Synopsis Immunogenic Cell Death in Cancer: From Benchside Research to Bedside Reality by : Abhishek D Garg
Download or read book Immunogenic Cell Death in Cancer: From Benchside Research to Bedside Reality written by Abhishek D Garg and published by Frontiers Media SA. This book was released on 2016-04-29 with total page 147 pages. Available in PDF, EPUB and Kindle. Book excerpt: Classically, anti-cancer therapies have always been applied with the primary aim of tumor debulking achieved through widespread induction of cancer cell death. While the role of host immune system is frequently considered as host protective in various (antigen-bearing) pathologies or infections yet in case of cancer overtime it was proposed that the host immune system either plays no role in therapeutic efficacy or plays a limited role that is therapeutically unemployable. The concept that the immune system is dispensable for the efficacy of anticancer therapies lingered on for a substantial amount of time; not only because evidence supporting the claim that anti-cancer immunity played a role were mainly contradictory, but also largely because it was considered acceptable (and sometimes still is) to test anticancer therapies in immunodeficient mice (i.e. SCID/athymic mice lacking adaptive immune system). This latter practice played a detrimental role in appreciating the role of anticancer immunity in cancer therapy. This scenario is epitomized by the fact that for a long time the very existence of cancer-associated antigens or cancer-associated ‘danger signaling’ remained controversial. However, over last several years this dogmatic view has been considerably modified. The existence of cancer-associated antigens and ‘danger signaling’ has been proven to be incontrovertible. These developments have together paved way for the establishment of the attractive concept of “immunogenic cell death” (ICD). It has been established that a restricted class of chemotherapeutics/targeted therapeutics, radiotherapy, photodynamic therapy and certain oncolytic viruses can induce a form of cancer cell death called ICD which is accompanied by spatiotemporally defined emission of danger signals. These danger signals along with other factors help cancer cells undergoing ICD to activate host innate immune cells, which in turn activate T cell-based immunity that helps eradicate live (or residual) surviving cancer cells. The emergence of ICD has been marred by some controversy. ICD has been criticized to be either experimental model or setting-specific or mostly a concept based on rodent studies that may have very limited implications for clinical application. However, in recent times it has emerged (through mainly retrospective or prognostic studies) that ICD can work in various human clinical settings hinting towards clinical applicability of ICD. However a widespread consensus on this issue is still transitional. In the current Research Topic we aimed to organize and intensify a discussion that strives to bring together the academic and clinical research community in order to provide a background to the current state-of-the-art in ICD associated bench-side research and to initiate fruitful discussions on present and future prospects of ICD translating towards the clinical, bedside reality.
Book Synopsis Biomaterials for Cancer Therapeutics by : Kinam Park
Download or read book Biomaterials for Cancer Therapeutics written by Kinam Park and published by Woodhead Publishing. This book was released on 2020-03-05 with total page 783 pages. Available in PDF, EPUB and Kindle. Book excerpt: Biomaterials for Cancer Therapeutics: Evolution and Innovation, Second Edition, discusses the role and potential of biomaterials in treating this prevalent disease. The first part of the book discusses the fundamentals of biomaterials for cancer therapeutics. Part Two discusses synthetic vaccines, proteins and polymers for cancer therapeutics. Part Three focuses on theranosis and drug delivery systems, while the final set of chapters look at biomaterial therapies and cancer cell interaction. Cancer affects people of all ages, and approximately one in three people are estimated to be diagnosed with cancer during their lifetime. Extensive research is being undertaken by many different institutions to explore potential new therapeutics, and biomaterials technology is being developed to target, treat and prevent cancer. Hence, this book is a welcomed resource to the discussion. - Provides a complete overview of the latest research into the potential of biomaterials for the diagnosis, treatment and prevention of cancer - Discusses how the properties of specific biomaterials make them important in cancer treatment - Covers synthetic vaccines, proteins and polymers for cancer therapeutics
Book Synopsis Epigenetic Regulation in Cancer Immunity by : Bo Chen
Download or read book Epigenetic Regulation in Cancer Immunity written by Bo Chen and published by Frontiers Media SA. This book was released on 2023-06-21 with total page 199 pages. Available in PDF, EPUB and Kindle. Book excerpt:
